BACKGROUND: Infections of the esophagus are rare and most commonly seen in children with immune suppression resulting from malignancy, chronic metabolic or infectious disease, or immunosuppressive drug therapy. METHODS: An 18-month-old girl on inhaled corticosteroid for bronchial asthma presented with coffee-ground emesis and melena. Upper endoscopy revealed yellow-white plaques scattered over the mucosa of the distal esophagus. Biopsy results showed chronic esophagitis with features of reflux disease. Gram staining of esophageal brushing showed pseudohyphae, and the culture was positive for candida species. RESULTS: The patient was treated with omeprazole 2 mg/kg per day and fluconazole 6 mg/kg per day for three weeks. Immunological workup was normal and she was negative for human immunodeficiency virus. Post treatment endoscopy showed normal appearance of esophageal mucosa and normal histology. At 12 months after treatment, the child remained asymptomatic and continued to thrive. CONCLUSIONS: We believe that this child developed esophageal candidiasis secondary to long-term use of inhaled corticosteroid associated with immune suppression on a background of reflux esophagitis. Anti-acid and antifungal therapies are effective in the treatment.
BACKGROUND: Infections of the esophagus are rare and most commonly seen in children with immune suppression resulting from malignancy, chronic metabolic or infectious disease, or immunosuppressive drug therapy. METHODS: An 18-month-old girl on inhaled corticosteroid for bronchial asthma presented with coffee-ground emesis and melena. Upper endoscopy revealed yellow-white plaques scattered over the mucosa of the distal esophagus. Biopsy results showed chronic esophagitis with features of reflux disease. Gram staining of esophageal brushing showed pseudohyphae, and the culture was positive for candida species. RESULTS: The patient was treated with omeprazole 2 mg/kg per day and fluconazole 6 mg/kg per day for three weeks. Immunological workup was normal and she was negative for human immunodeficiency virus. Post treatment endoscopy showed normal appearance of esophageal mucosa and normal histology. At 12 months after treatment, the child remained asymptomatic and continued to thrive. CONCLUSIONS: We believe that this child developed esophageal candidiasis secondary to long-term use of inhaled corticosteroid associated with immune suppression on a background of reflux esophagitis. Anti-acid and antifungal therapies are effective in the treatment.
Authors: A Chocarro Martínez; F Galindo Tobal; G Ruiz-Irastorza; A González López; F Alvarez Navia; C Ochoa Sangrador; M I Martín Arribas Journal: Eur J Clin Microbiol Infect Dis Date: 2000-02 Impact factor: 3.267
Authors: M López-Dupla; P Mora Sanz; V Pintado García; E Valencia Ortega; P L Uriol; M A Khamashta; A G Aguado Journal: Am J Gastroenterol Date: 1992-12 Impact factor: 10.864
Authors: Katie L Mason; John R Erb Downward; Nicole R Falkowski; Vincent B Young; John Y Kao; Gary B Huffnagle Journal: Infect Immun Date: 2011-10-10 Impact factor: 3.441
Authors: Vishwanath Sathyanarayanan; Abdul Razak; M Mukhyprana Prabhu; Kavitha Saravu; Pai C Ganesh; Anuradha K Rao Journal: Asian Pac J Trop Biomed Date: 2011-06
Authors: Elham Hossny; Nelson Rosario; Bee Wah Lee; Meenu Singh; Dalia El-Ghoneimy; Jian Yi Soh; Peter Le Souef Journal: World Allergy Organ J Date: 2016-08-12 Impact factor: 4.084